Pune, May 28, 2020 (GLOBE NEWSWIRE) -- The global Nebulizer market size is projected to reach USD 1,778.8 million by 2027, exhibiting a CAGR of 8.1% during the forecast period. Increasing prevalence ...
A new solution may be on the horizon for the 30 million people in the U.S. who suffer from sleep apnea. In a Finland study, a new breathing device showed promising results in reducing symptoms of the ...
Small breathing device could improve respiratory health and fitness levels of people with long COVID
New research presented at The Physiological Society's Long COVID: Mechanisms, Risk Factors, and Recovery on 22 – 23 February shows that a small handheld breathing device helped reduced breathlessness ...
Medicare classifies nebulizers as durable medical equipment (DME), which is covered under Part B. Part A may cover costs if needed during inpatient care in a clinic, hospital, or nursing facility.
The surge of COVID-19 infections in low- and middle-income countries requires alternative strategies to those implemented in wealthier nations. In response, the World Health Organisation is ...
The manufacturer, Philips Respironics, said it would compensate users of CPAP machines and other flawed devices that were recalled after they blew bits of foam into consumers’ mouths and lungs. By ...
Lawsuits claim the company, Philips Respironics, knew of problems with its breathing machines long before notifying customers of potential health risks. By Christina Jewett By 2015, Philips ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results